Momenta (MNTA) Crushed as Amphastar Wins Appeals Court Stay in Generic LOVENOX Case
Tweet Send to a Friend
Get Alerts MNTA Hot Sheet
Up)
Trade MNTA Now!
Momenta Pharmaceuticals Inc. (Nasdaq: MNTA) is getting crushed Thursday, down about 17 percent early in the session.
Shares are moving on the news that Amphastar won appeals court stay in generic LOVENOX case. LOVENOX is made by Watson Pharma (NYSE: WPI). Watson and Amphastar argued LOVENOX appeal on January 24th.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Shares are moving on the news that Amphastar won appeals court stay in generic LOVENOX case. LOVENOX is made by Watson Pharma (NYSE: WPI). Watson and Amphastar argued LOVENOX appeal on January 24th.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Yahoo! (YHOO) Board Said to Approve $1.1B Tumblr Deal
- Tableau Software (DATA) IPO indicated $37-$40 after pricing at $31
- UPDATE: Student Loan Rates Set for Change; ITT (ESI) & Corinthian (COCO) on Move
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Litigation, Momentum Movers
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
